share_log

HC Wainwright & Co. Maintains Buy on Sana Biotechnology, Raises Price Target to $11

Benzinga ·  Jan 8 22:13

HC Wainwright & Co. analyst Emily Bodnar maintains Sana Biotechnology (NASDAQ:SANA) with a Buy and raises the price target from $8 to $11.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment